Eye-Docs Limited iXBRL


Relate AccountsProduction v2.5.2 v2.5.2 2021-01-01 The company was not dormant during the period The company was trading for the entire period Specialists medical practice activities. 8 July 2022 50 32 04414314 2021-12-31 04414314 2020-12-31 04414314 2019-12-31 04414314 2021-01-01 2021-12-31 04414314 2020-01-01 2020-12-31 04414314 uk-bus:PrivateLimitedCompanyLtd 2021-01-01 2021-12-31 04414314 uk-bus:AbridgedAccounts 2021-01-01 2021-12-31 04414314 uk-core:ShareCapital 2021-12-31 04414314 uk-core:ShareCapital 2020-12-31 04414314 uk-core:RetainedEarningsAccumulatedLosses 2021-12-31 04414314 uk-core:RetainedEarningsAccumulatedLosses 2020-12-31 04414314 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2021-12-31 04414314 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2020-12-31 04414314 uk-bus:FRS102 2021-01-01 2021-12-31 04414314 uk-core:Land 2021-01-01 2021-12-31 04414314 uk-core:PlantMachinery 2021-01-01 2021-12-31 04414314 uk-bus:Audited 2021-01-01 2021-12-31 04414314 uk-core:ParentEntities 2021-01-01 2021-12-31 04414314 uk-countries:England 2021-01-01 2021-12-31 04414314 uk-bus:Director1 2021-01-01 2021-12-31 04414314 uk-bus:Director2 2021-01-01 2021-12-31 04414314 uk-bus:Director3 2021-01-01 2021-12-31 04414314 uk-bus:Director4 2021-01-01 2021-12-31 xbrli:pure iso4217:GBP xbrli:shares
Company Registration Number: 04414314
 
 
Eye-Docs Limited
 
Abridged Financial Statements
 
for the financial year ended 31 December 2021
Eye-Docs Limited
Company Registration Number: 04414314
ABRIDGED STATEMENT OF FINANCIAL POSITION
as at 31 December 2021

2021 2020
Notes £ £
 
Fixed Assets
Tangible assets 5 254,411 274,837
───────── ─────────
 
Current Assets
Stocks 107,026 75,311
Debtors 1,100,998 1,180,975
Cash and cash equivalents 558,759 741,545
───────── ─────────
1,766,783 1,997,831
───────── ─────────
Creditors: amounts falling due within one year (1,222,148) (610,227)
───────── ─────────
Net Current Assets 544,635 1,387,604
───────── ─────────
Total Assets less Current Liabilities 799,046 1,662,441
 
Creditors:
amounts falling due after more than one year - (37,469)
 
Provisions for liabilities 3,695 15,112
───────── ─────────
Net Assets 802,741 1,640,084
═════════ ═════════
 
Capital and Reserves
Called up share capital 80 80
Retained earnings 802,661 1,640,004
───────── ─────────
Equity attributable to owners of the company 802,741 1,640,084
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.
           
The company has taken advantage of the exemption under section 444 not to file the Abridged Income Statement and Directors' Report.
           
Approved by the Board and authorised for issue on 8 July 2022 and signed on its behalf by
           
________________________________          
T Kipioti          
Director          
           
________________________________
S Shah
Director
           
________________________________          
J Moore          
Director          
           
________________________________
R Sivaraj
Director
           



Eye-Docs Limited
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
for the financial year ended 31 December 2021

   
1. General Information
 
Eye-Docs Limited is a company limited by shares incorporated and registered in the United Kingdom. The registered number of the company is 04414314. The registered office of the company is 50 Lode Lane, Solihull, West Midlands, B91 2AW which is also the principal place of business of the company. Specialists medical practice activities. The financial statements have been presented in Pound Sterling (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the financial year ended 31 December 2021 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Turnover
Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.
 
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revisiion affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
 
Tangible assets and depreciation
Tangible assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:
 
  Long leasehold property - 20% Straight line
  Plant and machinery - 20% Straight line
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Leasing and hire purchases
Tangible assets held under leasing and Hire Purchases arrangements which transfer substantially all the risks and rewards of ownership to the company are capitalised and included in the Statement of Financial Position at their cost or valuation, less depreciation. The corresponding commitments are recorded as liabilities. Payments in respect of these obligations are treated as consisting of capital and interest elements, with interest charged to the Income Statement.
 
Stocks
Stocks are valued at the lower of cost and net realisable value. Stocks are determined on a first-in first-out basis. Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition.  Full provision is made for obsolete and slow moving items. Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Provisions
Provisions are recognised when the company has a present legal or constructive obligation arising as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the same value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognised as interest expense.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recoginsed as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the emploee's services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
 
Taxation and deferred taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Statement of Financial Position date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Statement of Financial Position date.
 
Government grants
Capital grants received and receivable are treated as deferred income and amortised to the Income Statement annually over the useful economic life of the asset to which it relates. Revenue grants are credited to the Income Statement when received.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
   
3. INFORMATION RELATING TO THE AUDITOR'S REPORT
 
The Audit Report was unqualified. There were no matters to which the auditor was required to refer by way of emphasis.
 
The financial statements were audited by Muldoon & Co.
The Auditor's Report was signed by Robert Barr (Senior Statutory Auditor) for and on behalf of Muldoon & Co on 8th July 2022.
 
       
4. Employees
 
The average monthly number of employees, including directors, during the financial year was:
 
  2021 2020
  Number Number
 
Employees 50 32
  ═════════ ═════════
         
5. Tangible assets
  Long Plant and Total
  leasehold machinery  
  property    
  £ £ £
Cost
At 1 January 2021 562,521 1,375,190 1,937,711
Additions - 67,596 67,596
  ───────── ───────── ─────────
At 31 December 2021 562,521 1,442,786 2,005,307
  ───────── ───────── ─────────
Depreciation
At 1 January 2021 552,886 1,109,988 1,662,874
Charge for the financial year 6,803 81,219 88,022
  ───────── ───────── ─────────
At 31 December 2021 559,689 1,191,207 1,750,896
  ───────── ───────── ─────────
Net book value
At 31 December 2021 2,832 251,579 254,411
  ═════════ ═════════ ═════════
At 31 December 2020 9,635 265,202 274,837
  ═════════ ═════════ ═════════
       
6. Capital commitments
 
The company had no material capital commitments at the financial year-ended 31 December 2021.
   
7. Parent company
 
From the beginning of the year until 6th August 2021, the immediate parent entity was Aspen Healthcare Limited, a company incorporated in England and Wales. After this date, the immediate parent entity was Midland Eye Holdings Limited, a company incorporated  in England and Wales.

From the beginning of the year until 6th August 2021, the ultimate controlling party was NMC Health Plc, a United Arab Emirates based company. On 6th August 2021, North West Healthcare REIT, a Canadian listed Real Estate Trust became the company's new ultimate controlling party.

On 21st December 2021, Eye-Docs Holdings Limited, a company incorporated in England and Wales, became the new ultimate controlling party.
 
   
8. Events After the End of the Reporting Period
 
There have been no significant events affecting the company since the financial year-end.